Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PRR16 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Prr16 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRR16 mRNA | CTD | PMID:36331819 | PRR16 | Human | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of PRR16 mRNA | CTD | PMID:22574217 | PRR16 | Human | 17beta-estradiol | multiple interactions | ISO | Prr16 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PRR16 mRNA | CTD | PMID:32741896 | PRR16 | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Prr16 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PRR16 mRNA | CTD | PMID:32741896 | PRR16 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Prr16 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of PRR16 mRNA | CTD | PMID:16214954 | PRR16 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Prr16 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PRR16 mRNA | CTD | PMID:26377647 | PRR16 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Prr16 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PRR16 mRNA | CTD | PMID:26290441 | PRR16 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of PRR16 mRNA | CTD | PMID:21179406 | PRR16 | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of PRR16 mRNA | CTD | PMID:37199045 | PRR16 | Human | 4-hydroxyphenyl retinamide | decreases expression | ISO | Prr16 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of PRR16 mRNA | CTD | PMID:28973697 | PRR16 | Human | 6-propyl-2-thiouracil | affects expression | ISO | Prr16 (Rattus norvegicus) | 6480464 | Propylthiouracil affects the expression of PRR16 mRNA | CTD | PMID:24780913 | PRR16 | Human | acetamide | decreases expression | ISO | Prr16 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of PRR16 mRNA | CTD | PMID:31881176 | PRR16 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of PRR16 gene | CTD | PMID:27153756 | PRR16 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of PRR16 exon | CTD | PMID:30157460 | PRR16 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of PRR16 mRNA | CTD | PMID:21934132 and PMID:23724009 | PRR16 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of PRR16 gene | CTD | PMID:25304211 | PRR16 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of PRR16 gene | CTD | PMID:25304211 | PRR16 | Human | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of PRR16 promoter | CTD | PMID:23974009 | PRR16 | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to PRR16 mRNA] | CTD | PMID:32406909 | PRR16 | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of PRR16 mRNA | CTD | PMID:15761015 | PRR16 | Human | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of PRR16 mRNA | CTD | PMID:26705709 | PRR16 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PRR16 5' UTR | CTD | PMID:27901495 | PRR16 | Human | bisphenol A | affects expression | ISO | Prr16 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of PRR16 mRNA | CTD | PMID:25181051 | PRR16 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PRR16 gene | CTD | PMID:31601247 | PRR16 | Human | bisphenol A | increases expression | ISO | Prr16 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PRR16 mRNA | CTD | PMID:32145629 | PRR16 | Human | bisphenol F | increases expression | ISO | Prr16 (Mus musculus) | 6480464 | bisphenol F results in increased expression of PRR16 mRNA | CTD | PMID:38685157 | PRR16 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of PRR16 mRNA | CTD | PMID:21592394 | PRR16 | Human | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of PRR16 mRNA | CTD | PMID:21592394 and PMID:26485663 | PRR16 | Human | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of PRR16 mRNA | CTD | PMID:20971185 | PRR16 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of PRR16 mRNA | CTD | PMID:20971185 | PRR16 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of PRR16 mRNA | CTD | PMID:20106945 | PRR16 | Human | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of PRR16 mRNA | CTD | PMID:25136773 | PRR16 | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of PRR16 mRNA | CTD | PMID:15761015 | PRR16 | Human | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of PRR16 mRNA | CTD | PMID:26705709 | PRR16 | Human | Didecyldimethylammonium | decreases expression | EXP | | 6480464 | didecyldimethylammonium results in decreased expression of PRR16 mRNA | CTD | PMID:32763356 | PRR16 | Human | dioxygen | multiple interactions | ISO | Prr16 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRR16 mRNA | CTD | PMID:30529165 | PRR16 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | PRR16 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of PRR16 mRNA | CTD | PMID:29803840 | PRR16 | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of PRR16 mRNA | CTD | PMID:26272509 | PRR16 | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR16 mRNA | CTD | PMID:27188386 | PRR16 | Human | epoxiconazole | increases expression | ISO | Prr16 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of PRR16 mRNA | CTD | PMID:35436446 | PRR16 | Human | folic acid | affects expression | EXP | | 6480464 | Folic Acid affects the expression of PRR16 mRNA | CTD | PMID:17320366 | PRR16 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PRR16 gene | CTD | PMID:31601247 | PRR16 | Human | glycidol | decreases expression | ISO | Prr16 (Rattus norvegicus) | 6480464 | glycidol results in decreased expression of PRR16 mRNA | CTD | PMID:24915197 | PRR16 | Human | ketamine | decreases expression | ISO | Prr16 (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of PRR16 mRNA | CTD | PMID:20080153 | PRR16 | Human | lithium chloride | decreases expression | EXP | | 6480464 | Lithium Chloride results in decreased expression of PRR16 mRNA | CTD | PMID:15711924 | PRR16 | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of PRR16 mRNA | CTD | PMID:24768652 | PRR16 | Human | nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of PRR16 mRNA | CTD | PMID:22714537 | PRR16 | Human | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR16 mRNA | CTD | PMID:27188386 | PRR16 | Human | panobinostat | increases expression | EXP | | 6480464 | panobinostat results in increased expression of PRR16 mRNA | CTD | PMID:26272509 | PRR16 | Human | paracetamol | affects expression | ISO | Prr16 (Mus musculus) | 6480464 | Acetaminophen affects the expression of PRR16 mRNA | CTD | PMID:17562736 | PRR16 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Prr16 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRR16 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PRR16 mRNA | CTD | PMID:36331819 | PRR16 | Human | phenobarbital | increases expression | ISO | Prr16 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of PRR16 mRNA | CTD | PMID:19270015 | PRR16 | Human | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of PRR16 mRNA | CTD | PMID:26272509 | PRR16 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR16 mRNA | CTD | PMID:27188386 | PRR16 | Human | pirinixic acid | multiple interactions | ISO | Prr16 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PRR16 mRNA | CTD | PMID:19710929 | PRR16 | Human | pirinixic acid | decreases expression | ISO | Prr16 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of PRR16 mRNA | CTD | PMID:23811191 | PRR16 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of PRR16 mRNA | CTD | PMID:22714537 | PRR16 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | PRR16 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of PRR16 mRNA | CTD | PMID:25351596 | PRR16 | Human | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of PRR16 mRNA | CTD | PMID:21592394 | PRR16 | Human | testosterone | multiple interactions | ISO | Prr16 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PRR16 mRNA | CTD | PMID:32741896 | PRR16 | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of PRR16 mRNA | CTD | PMID:21592394 and PMID:33359661 | PRR16 | Human | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of PRR16 mRNA | CTD | PMID:22378314 | PRR16 | Human | thioacetamide | decreases expression | ISO | Prr16 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of PRR16 mRNA | CTD | PMID:34492290 | PRR16 | Human | titanium dioxide | decreases methylation | ISO | Prr16 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of PRR16 promoter | CTD | PMID:35295148 | PRR16 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of PRR16 mRNA | CTD | PMID:24935251 | PRR16 | Human | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of PRR16 mRNA | CTD | PMID:22378314 | PRR16 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of PRR16 mRNA | CTD | PMID:23179753 | PRR16 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of PRR16 mRNA | CTD | PMID:24383497 more ... | |